Where are we now and where do we go next in terms of the scientific basis for regulation on bioavailability and bioequivalence? FDA Biopharmaceutics Coordinating Committee

Eur J Drug Metab Pharmacokinet. 2000 Jan-Mar;25(1):7-12. doi: 10.1007/BF03190049.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Biological Availability
  • Documentation / methods
  • Documentation / standards
  • Drug Industry
  • Forecasting
  • Humans
  • Pharmacokinetics*
  • Therapeutic Equivalency